On Tuesday, the SPDR S&P Biotech ETF rose approximately 3.2%, outperforming other ETFs. Key contributors to this increase included Mineralys Therapeutics, which surged about 87%, and Cytokinetics, up 40.7%.
In contrast, the VanEck Rare Earth/Strategic Metals ETF fell about 3.5%. Significant declines within this ETF included shares of Sigma Lithium, down 7.8%, and MP Materials, down 6.2%.
